{"meta":{"query_hash":"2e648224afc0","filters":{"venue":"Surgical Update International Journal of Surgery and Orthopedics"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2e648224afc0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Surgical+Update+International+Journal+of+Surgery+and+Orthopedics"},"results":[{"id":"W3020398921","doi":"10.17511/ijoso.2019.i03.09","title":"A real life experience with novel biosimilar InfimabTM in biologic naive patients with active rheumatoid arthritis","year":2019,"lang":"en","type":"article","venue":"Surgical Update International Journal of Surgery and Orthopedics","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Biosimilar; Erythrocyte sedimentation rate; Rheumatoid arthritis; Infliximab; Internal medicine; Adverse effect; Visual analogue scale; Methotrexate; Physical therapy; Disease","score_opus":0.014851527391208853,"score_gpt":0.25739482511318906,"score_spread":0.24254329772198022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020398921","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981014,0.0007820779,0.000278477,0.0001360563,0.00001679849,0.00003865468,0.000038078775,0.0000072656385,0.00060117076],"genre_scores_gemma":[0.99822015,0.00040664827,0.00048651255,0.00020854828,0.0000705393,0.000037889677,0.000092872964,0.000002271978,0.00047460772],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99955255,0.00026619545,0.000027382432,0.000053304168,0.000054301512,0.000046224803],"domain_scores_gemma":[0.9992518,0.00021513306,0.00015224362,0.000049944545,0.00007474818,0.0002560322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011373683,0.00022419053,0.00039276094,0.000080442696,0.00035577035,0.00038479248,0.00018831508,0.00043296834,0.00178951],"category_scores_gemma":[0.0020102502,0.00009083877,0.00024073581,0.00008534211,0.00024732554,0.0003182164,0.00030512427,0.00057139277,0.0005376937],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072508246,0.053677246,0.3168015,0.0013602468,0.00045286183,0.013924384,0.014992955,0.0025298032,0.07217301,0.000714407,0.00581315,0.44505224],"study_design_scores_gemma":[0.012834659,0.57640505,0.32439733,0.00016622538,0.00045263278,0.029658897,0.0032576574,0.0040353574,0.014894807,0.00043514866,0.03331213,0.000150125],"about_ca_topic_score_codex":0.00017482082,"about_ca_topic_score_gemma":0.00018097839,"teacher_disagreement_score":0.00178951,"about_ca_system_score_codex":0.0001879307,"about_ca_system_score_gemma":0.00013218887,"threshold_uncertainty_score":0.0060150027},"labels":[],"label_agreement":null}]}